Other Events ·
At its 2026 Annual Meeting of Shareholders on July 14, 2026, Entera Bio Ltd. shareholders approved an amendment to the…
ENTXWEntera Bio Ltd.
At its 2026 Annual Meeting of Shareholders on July 14, 2026, Entera Bio Ltd. shareholders approved an amendment to the 2018 Equity Incentive Plan to increase the number of ordinary shares issuable by 2,500,000 shares. Additionally, shareholders approved an amendment to the Articles of Association to increase the authorized Ordinary Shares from 140,010,000 to 350,000,000. Entera Bio Ltd. is a biotechnology company focused on developing oral peptide therapeutics.